Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers

      FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers

      supriya kashyap kashyap28 March 2017 9:37 AM IST
      The U.S. Food and Drug Administration approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients...
      EMA panel backs Novo Nordisks hemophilia B drug

      EMA panel backs Novo Nordisk's hemophilia B drug

      supriya kashyap kashyap27 March 2017 3:59 PM IST
      A panel of the European Medicines Agency said it recommended granting marketing approval to Danish drug maker Novo Nordisk's hemophilia B drug.The...
      Suspend 300 drugs tested by desi firm- European Drug Regulator

      Suspend 300 drugs tested by desi firm- European Drug Regulator

      supriya kashyap kashyap27 March 2017 11:11 AM IST
      New Delhi : The European drug regulator has recommended suspension of around 300 medicines on which bioequivalence studies were conducted by...
      Drug maker Lilly to invest $850 million in US operations in 2017

      Drug maker Lilly to invest $850 million in US operations in 2017

      supriya kashyap kashyap27 March 2017 11:10 AM IST
      Eli Lilly and Co said it would invest $850 million in its U.S. operations this year, and the drug maker signaled it would be willing to spend more if...
      Almirall seeks nod for tildrakizumab in Europe: Sun Pharma

      Almirall seeks nod for tildrakizumab in Europe: Sun Pharma

      supriya kashyap kashyap26 March 2017 11:11 AM IST
      New Delhi : Drug major Sun Pharmaceutical Industries said Spain-based Almirall S.L has sought regulatory approval from the European Medicines Agency...
      Investments set India as hot healthcare destination: PWC Report

      Investments set India as hot healthcare destination: PWC Report

      supriya kashyap kashyap26 March 2017 11:08 AM IST
      Mumbai : Private equity and venture capital funding in healthcare over the past five years along with a slew of investments from global players has...
      Pact to check misleading ads of Ayurvedic medicines

      Pact to check misleading ads of Ayurvedic medicines

      supriya kashyap kashyap26 March 2017 10:11 AM IST
      New Delhi : The government has signed a pact with the Advertising Standards Council of India to check misleading advertisements of Ayurvedic...
      CCI seeks fresh application in Bayer-Monsanto deal

      CCI seeks fresh application in Bayer-Monsanto deal

      supriya kashyap kashyap26 March 2017 10:11 AM IST
      New Delhi : The Competition Commission has asked for filing of fresh application with respect to German major Bayer AG's proposed USD 66 billion...
      Taking steps to reduce dependence on API imports: Government

      Taking steps to reduce dependence on API imports: Government

      supriya kashyap kashyap25 March 2017 11:02 AM IST
      New Delhi : The government said it was working on steps to reduce India's dependence on large scale import of active pharmaceutical ingredients...
      Lupin receives FDA approval for generic TOBI inhalation solution

      Lupin receives FDA approval for generic TOBI inhalation solution

      supriya kashyap kashyap25 March 2017 10:59 AM IST
      Mumbai : Pharma Major Lupin Limited announced that it has received final approval for its Tobramycin Inhalation Solution USP, 300 mg/5 ml from the...
      USFDA issues warning letter to USV Pvt over Daman plant

      USFDA issues warning letter to USV Pvt over Daman plant

      supriya kashyap kashyap25 March 2017 10:59 AM IST
      New Delhi : The US health regulator has red-flagged Mumbai-based drug firm USV Pvt Ltd for violations of manufacturing norms, including data integrity...
      Piramal acquires Mallinckrodt LLCs pain drug portfolio

      Piramal acquires Mallinckrodt LLC's pain drug portfolio

      supriya kashyap kashyap25 March 2017 10:58 AM IST
      New Delhi : Piramal Enterprises said it has completed acquisition of a portfolio of drugs for spasticity and pain management from Mallinckrodt...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok